CERS
Price
$1.68
Change
+$0.11 (+7.01%)
Updated
Jan 3 closing price
46 days until earnings call
VCYT
Price
$41.91
Change
+$1.47 (+3.64%)
Updated
Jan 3 closing price
56 days until earnings call
Ad is loading...

CERS vs VCYT

Header iconCERS vs VCYT Comparison
Open Charts CERS vs VCYTBanner chart's image
Cerus
Price$1.68
Change+$0.11 (+7.01%)
Volume$1.06M
CapitalizationN/A
Veracyte
Price$41.91
Change+$1.47 (+3.64%)
Volume$414.3K
CapitalizationN/A
CERS vs VCYT Comparison Chart
Loading...
CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CERS vs. VCYT commentary
Jan 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CERS is a Hold and VCYT is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 06, 2025
Stock price -- (CERS: $1.68 vs. VCYT: $41.91)
Brand notoriety: CERS and VCYT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CERS: 75% vs. VCYT: 53%
Market capitalization -- CERS: $342.62M vs. VCYT: $1.66B
CERS [@Medical Specialties] is valued at $342.62M. VCYT’s [@Medical Specialties] market capitalization is $1.66B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CERS’s FA Score shows that 0 FA rating(s) are green whileVCYT’s FA Score has 0 green FA rating(s).

  • CERS’s FA Score: 0 green, 5 red.
  • VCYT’s FA Score: 0 green, 5 red.
According to our system of comparison, VCYT is a better buy in the long-term than CERS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CERS’s TA Score shows that 4 TA indicator(s) are bullish while VCYT’s TA Score has 5 bullish TA indicator(s).

  • CERS’s TA Score: 4 bullish, 5 bearish.
  • VCYT’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, VCYT is a better buy in the short-term than CERS.

Price Growth

CERS (@Medical Specialties) experienced а +7.69% price change this week, while VCYT (@Medical Specialties) price change was +4.46% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.44%. For the same industry, the average monthly price growth was +1.98%, and the average quarterly price growth was +5.38%.

Reported Earning Dates

CERS is expected to report earnings on Feb 20, 2025.

VCYT is expected to report earnings on May 06, 2025.

Industries' Descriptions

@Medical Specialties (+2.44% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VCYT($1.66B) has a higher market cap than CERS($343M). CERS YTD gains are higher at: 9.091 vs. VCYT (5.833). CERS has higher annual earnings (EBITDA): -26.34M vs. VCYT (-49.41M). VCYT has more cash in the bank: 216M vs. CERS (65.9M). VCYT has less debt than CERS: VCYT (12.6M) vs CERS (96M). VCYT has higher revenues than CERS: VCYT (361M) vs CERS (156M).
CERSVCYTCERS / VCYT
Capitalization343M1.66B21%
EBITDA-26.34M-49.41M53%
Gain YTD9.0915.833156%
P/E RatioN/AN/A-
Revenue156M361M43%
Total Cash65.9M216M31%
Total Debt96M12.6M762%
FUNDAMENTALS RATINGS
CERS vs VCYT: Fundamental Ratings
CERS
VCYT
OUTLOOK RATING
1..100
2850
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
39
Fair valued
PROFIT vs RISK RATING
1..100
10076
SMR RATING
1..100
9790
PRICE GROWTH RATING
1..100
7338
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VCYT's Valuation (39) in the Biotechnology industry is in the same range as CERS (47) in the Medical Specialties industry. This means that VCYT’s stock grew similarly to CERS’s over the last 12 months.

VCYT's Profit vs Risk Rating (76) in the Biotechnology industry is in the same range as CERS (100) in the Medical Specialties industry. This means that VCYT’s stock grew similarly to CERS’s over the last 12 months.

VCYT's SMR Rating (90) in the Biotechnology industry is in the same range as CERS (97) in the Medical Specialties industry. This means that VCYT’s stock grew similarly to CERS’s over the last 12 months.

VCYT's Price Growth Rating (38) in the Biotechnology industry is somewhat better than the same rating for CERS (73) in the Medical Specialties industry. This means that VCYT’s stock grew somewhat faster than CERS’s over the last 12 months.

VCYT's P/E Growth Rating (100) in the Biotechnology industry is in the same range as CERS (100) in the Medical Specialties industry. This means that VCYT’s stock grew similarly to CERS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CERSVCYT
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
75%
Momentum
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
79%
MACD
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
76%
Declines
ODDS (%)
Bearish Trend 6 days ago
83%
Bearish Trend 6 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
83%
Aroon
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
81%
View a ticker or compare two or three
Ad is loading...
CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ESGIX15.610.20
+1.30%
Dana Epiphany Equity Inst
PAGYX19.930.19
+0.96%
Putnam Dynamic Asset Allocation Gr Y
SESVX22.270.19
+0.86%
SEI Small Cap Value F (SIMT)
OANMX152.891.12
+0.74%
Oakmark Institutional
VLAAX40.580.20
+0.50%
Value Line Asset Allocation Investor

CERS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CERS has been loosely correlated with MASS. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CERS jumps, then MASS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CERS
1D Price
Change %
CERS100%
+7.01%
MASS - CERS
47%
Loosely correlated
+4.57%
FLGT - CERS
44%
Loosely correlated
+1.85%
QDEL - CERS
41%
Loosely correlated
+3.60%
BNGO - CERS
40%
Loosely correlated
+24.05%
OFIX - CERS
40%
Loosely correlated
+0.52%
More